[1] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会等. 胆汁淤积性肝病诊断和治疗共识(2015). 实用肝脏病杂志,2016,19(6):771-781. [2] 程询,杨长青.检测门脉高压程度评估肝硬化严重程度研究进展.实用肝脏病杂志,2017,20(1):10-12. [3] 刘雪莲,杨见权.脾功能亢进症治疗进展.实用肝脏病杂志,2013,16(4):382-384. [4] Yao YM,Liu QG,Yang W,et al.Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.Hepatobiliary Pancreat Dis Int,2003,2(2):242-246. [5] 郭晓霞,李良学,武玉鹏,等. 聚肌胞苷酸诱导的早期原发性胆汁性肝硬化小鼠模型的建立. 实用肝脏病杂志,2014,17(6):619-622. [6] Irma M,Markku N.Human leukocyte antigen associations in Finnish liver transplantations due to primary sclerosing cholangitis and primary biliary cirrhosis. Open Med,2007,2(1):12-25. [7] Chuang N,Gross RG,Odin JA.Update on the epidemiology of primary biliarycirrhosis.Expert Rev Gastroenterol Hepatol,2011,5(5):583-590. [8] Liu H,Liu Y,Wang L,et al.Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol,2010,10(100):2-5. [9] Chan CW,Carpenter JR,Rigamonti C,et al.Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis:a staged prognostic model. Scand J Gastroenterol,2005,40(9):1081-1089. [10] 何方平,陈兰. 原发性胆汁性肝硬化的流行病学及自然病程研究进展. 实用肝脏病杂志,2013,16(2):97-98. [11] Cartin-Ceba R,Krowda MJ.Portopulmonary hypertension.Clin Liver Dis,2014,18(2):421-438. [12] Federica L,Caterina M.The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody(AMA)-negative PBC patients:a review of literature. Clin Chem Laborat Med,2017,56(1):25-31. [13] Morinaga A,Ogata T,Kage M,et al.Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model. HPB,2010,12(1):22-30. [14] Kaoru O,Kanako Y.Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter. Clin J Gastroenterol,2016,9(5):312-318. [15] Okada Y,Tsuzuki Y,Hokari R,et al.Pressure loading and ethanol exposure differentially modulate rat hepatic stellate cell activation. J Cell Physiol,2008,215(2):472-480. [16] 陈柳莹,陆伦根. 重视慢性肝病的病情评估. 实用肝脏病杂志,2017,20(1):4-6. [17] Mousa S,Carbone M.Novel therapeutics for primary biliary chol-angitis:Toward a disease-stage-based approach. Autoimmun Rev,2016,15(9):870-876. [18] Urrunaga N,Rockey D.Portal hypertensive gastropathy and colopathy. Clin Liver Dis,2014,18(2):389-406. [19] Norman K,Pirlich M.Gastrointestinal tract in liver disease:which organ is sick. Curr Opin Clin Nutr Metab Care,2008,11(5):613-619. [20] Hua F,Wang L.Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis. Clin Exp Immunol,2016,186(3):347-355. |